-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/joint-replacement-evidence%20-summary.pdf
November 01, 2021 - We assessed the risk of
bias and evaluated the SoE using standard methods.
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-231-dementia-interventions-evidence-summary_0.pdf
August 01, 2020 - Our approach
to risk of bias assessment was generous, relative to how risk of bias is assessed in more
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/ehc-presentation-quantitative-synthesis-chapter-1.pdf
July 01, 2019 - .
► Chapter 4 covers statistical heterogeneity in detail
• Statistical heterogeneity is assessed by
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/ace-inhibitor-arb-update_research-protocol.pdf
May 07, 2010 - Assessment of Methodological Quality of Individual Studies
The included studies will be assessed on … Grading the Evidence for Each Key Question
The strength of evidence for each key question will be assessed
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/mental-health-app-protocol-updated.pdf
January 01, 2018 - Interrater
reliability between the two reviewers will be assessed and any discrepancies in the
application … Interrater reliability
between the two
reviewers will be
assessed and any
discrepancies in the
application
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/hepatitis-c-screening_research-protocol.pdf
October 20, 2011 - statement of the research questions(s), reported inclusion
criteria, used an adequate search strategy, assessed … appropriateness of meta-analysis, we will consider the
clinical and methodological diversity and assessed
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/wheelchair-service_research-protocol.pdf
July 01, 2010 - Outcomes assessed (i.e., functional ability, utilization of chair, patient satisfaction,
quality of … patient
evaluation, provider, payer, fitting process, training and education, follow-up), outcomes
assessed
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/gastric-cancers-protocol.pdf
January 01, 2024 - ROBINS-I comprises seven domains which will each be assessed:
• Bias due to confounding
• Bias in … The primary domains assessed include risk of bias, directness, consistency, precision, and
reporting … How effects on health equity are
assessed in systematic reviews of interventions.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/gestational-diabetes-screening-diagnosis_research-protocol.pdf
December 16, 2011 - For the remaining questions, the internal validity of RCTs and NRCTs will be assessed using
the Cochrane … Blinding and incomplete outcome data will be assessed separately for subjective
outcomes (e.g., depression … If one or more
individual domains are assessed as having a high risk of bias, the overall score will
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cognitive-decline_research-protocol.pdf
March 22, 2016 - A number of reviews have assessed the evidence linking risk factors and
protective factors to Alzheimer … Additional data will be extracted from studies
assessed as having low to moderate risk of bias. … Assessment of Methodological Risk of Bias of Individual Studies
Risk of bias of eligible studies will be assessed
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cad-pci-bypass_addendum.pdf
February 01, 2010 - previously shown an effect of diabetes survival in patients randomized to
CABG and PCI.28 We also assessed … The composite endpoint of death or myocardial
infarction within 90 days, which could be assessed in … the proportional hazards assumption was not violated.
3
Several secondary endpoints could be assessed
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/diabetic-neuropathy-disposition-170707.pdf
March 24, 2017 - TEP #2 Results –
KQ2
Botulinum toxin SOE is assessed as moderate (Table
11, page 62). … Similarly, were dropout
rates due to lack of efficacy assessed? … We assessed
dropout rates due to side effects as a measure
of harm, as was done in previous meta-
analyses
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetic-neuropathy-disposition-170707.pdf
March 24, 2017 - TEP #2 Results –
KQ2
Botulinum toxin SOE is assessed as moderate (Table
11, page 62). … Similarly, were dropout
rates due to lack of efficacy assessed? … We assessed
dropout rates due to side effects as a measure
of harm, as was done in previous meta-
analyses
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-222-evidence-summary-health-equity.pdf
January 01, 2020 - inclusion, trials or observational studies with
comparison groups, or before-after studies that
assessed … The strength
of evidence and overall applicability for each KQ
and outcome were assessed by investigators … primarily designed
to evaluate interventions to increase use of a
preventive service, and barriers were assessed
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/version-2-risk-of-reinfection-from-SARSCoV2_0.pdf
December 31, 2022 - We assessed whether selection bias could arise from the data sources used to identify
eligible individuals … We assessed the methods used to ascertain new infections during the
followup period, such as scheduled … We assessed these visually for relationships with effect sizes using scatterplots and
nonparametric … Study heterogeneity within strata
was assessed using the I2 statistic, which estimates the fraction … Study heterogeneity across strata was assessed using Cochran's Qb
statistic, which follows a chi-squared
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-cholestorol-medicines-update_disposition-comments.pdf
September 01, 2014 - /day,
not moderate as previously stated
ES11(a): Serious adverse events (SAE) were abstracted and assessed … Risk of bias
was assessed appropriately with accepted
methods—Jadad doesn’t differ terribly from the … Serious adverse events (SAE) were abstracted and assessed as reported and
defined by the study investigators … Serious adverse events (SAE) were abstracted and assessed as reported and
defined by the study investigators … Commentator Section Comments Response
“Precise” because the method by which
precision was assessed
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-229-opioid-treatments-chronic-pain-evidence-summary.pdf
April 01, 2020 - recommendations in the CDC guideline, all
except for one (treatment for opioid use disorder)
were assessed … Preventive Services Task
Force,6 and studies of diagnostic accuracy were
assessed using Quality Assessment … Statistical heterogeneity was assessed using the
I2 statistic17 and the Cochran χ2 test. … limitations, and heterogeneity
across studies in interventions evaluated, study
designs, and outcomes assessed
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/skin-lesions-evaluation_technical-brief.pdf
December 01, 2014 - Outcomes assessed
v. Adverse events, harms, and safety issues reported
vi. … Outcomes assessed
e. Comparators used nd nd nd nd
f. … .27 Three studies, including 1 RCT,
assessed the use of photography in conjunction with mole mapping … The comparative cohort study assessed 15 patients with clinical
suspicion of epithelial cancers and … Test accuracy of many of these investigational modalities has not
been adequately assessed.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/sodium-potassium_research-protocol.pdf
April 18, 2017 - Short
communications such as conference abstracts cannot fairly be assessed for risk of bias,
peer … are included in the review as sources of data will have the risk of
bias of their included studies assessed … If the
systematic review has assessed the risk of bias for included studies using the Cochrane or
Newcastle … Statistical heterogeneity will be assessed and expressed as the I2 statistic and considered
in interpreting … Assessing Applicability
Applicability will be assessed at the level of the total body of evidence for
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/autism-update_disposition-comments.pdf
August 06, 2014 - Per EPC methods, strength of evidence is assessed for a
limited number of outcomes, usually those related … We have noted in the Methods section of
the report that we assessed strength of the evidence only
for … We agree and that is why we assessed the degree to
which concomitant interventions were held consistent … None of the
categories assessed have been defined and it’s not clear
how one takes a group of studies … were quite detailed and helpful, with the
exception of table 17 (insufficient evidence by outcomes
assessed